Respiratory Treatment and Prevention (Advances in Experimental Medicine and Biology)

S
Sarcoidosis, 1–6
Sleep apnea, 63–69
Sleep disordered breathing, 63
Smoking, 73–79, 81–84
Soluble receptor activator of nuclear factor-kappaB
(sRANKL) ligand, 1–6

T
Traveler malaria, 35–45
Treatment effectiveness, 65

Tropical disease, 36

Tumor necrosis factor alpha (TNF-α), 21,

74–79

U

Upper airways, 64, 65, 68, 69

V

Viruses, 38, 39, 48, 53–60

88 Index